MabThera subkutan 1600 mg/13.4 ml, Lösung zur subkutanen Injektion
7680658130026
CH-65813
Lösung
Associated product:
MABTHERA sous-cutané sol inj 1600 mg/13.4 ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rituximabum
|
1600.0 MG | Substance | Wirkstoff (Principe actif) |
|
hyaluronidasum humanum ADNr
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
methioninum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 65813
- Drug name
- MabThera subkutan, Lösung zur subkutanen Injektion
- Galenic form
- LSPA
- ATC Code
- L01FA01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 28/06/2016
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- MABTHERA sous-cutané sol inj 1600 mg/13.4 ml flac
- Description (DE)
- MABTHERA subkutan Inj Lös 1600 mg/13.4 ml Durchstf
- Market launch
- 08/05/2018
- Market withdrawal
- 01/07/2026
- Narcotic (BTM)
- No
Other package sizes (1)
MABTHERA sous-cutané sol inj 1400 mg/11.7 ml flac
1 DUR
GTIN: 7680658130019